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NOT PRECEDENTIAL
UNITED STATES COURT OF APPEALS
FOR THE THIRD CIRCUIT
____________
No. 04-3264
____________
MARCIA JAKUBOWSKI,
Appellant
v.
COMMISSIONER SOCIAL SECURITY
____________
On Appeal from the United States District Court
for the District of New Jersey
(D.C. No. 02-cv-05952)
District Judge: Honorable Dennis M. Cavanaugh
____________
Submitted Under Third Circuit LAR 34.1(a)
April 1, 2005
Before: ALITO, SMITH and FISHER, Circuit Judges.
(Filed: April 12, 2005)
____________
OPINION OF THE COURT
____________
FISHER, Circuit Judge.
Appellant Marcia Jakubowski appeals from a final order of the United States
District Court for the District of New Jersey affirming an order of the Commissioner of
Social Security denying her claims for disability insurance benefits under Title II of the

Social Security Act. Because we believe that the District Court erred in finding that
Appellant had failed to demonstrate that her seizure disorder was a “severe impairment”
at step two of the five-step sequential analysis, we will reverse the order of the District
Court.
As we write solely for the parties, and the facts are known to them, we will discuss
only those facts pertinent to this appeal. Appellant was awarded disability insurance
benefits effective September 1994 due to a seizure disorder. Following a disability
hearing in July 2000, the hearing officer found that her seizure “disability” had ceased as
of July 1999, and ordered her benefits terminated effective September 1999. At the time,
the only reports from physicians who had treated Appellant indicated that Appellant’s
seizures could be “well controlled with medication” and that Appellant herself had stated
that she “had been free from seizures for a one-year period with the medication[.]”
On September 13, 2000, following the hearing officer’s decision terminating
benefits, Appellant filed a Request for Hearing, and a hearing was scheduled for
March 26, 2001. Ultimately, an administrative law judge denied Appellant’s claim on
June 28, 2002. In the course of rejecting Appellant’s claim, the ALJ minimized the force
of the report of Appellant’s most recent treating physician, Dr. Melissa Ann Carran.
After treating Appellant in the Spring of 2002, Dr. Carran had opined in a May 13, 2002
report that Appellant was unable to work and that the medication she had been prescribed
to address her seizures, Dilantin, was a “failed medication.” The ALJ found that Dr.
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Carran’s opinion lacked any “medical basis” and generally disregarded it. The ALJ
concluded that Appellant had failed to demonstrate that her seizures constituted a “severe
impairment” as required under the five-step sequential evaluation framework, and
therefore denied her claim. The District Court affirmed the ALJ’s decision.
The District Court had jurisdiction pursuant to 42 U.S.C. § 405(g). We have
jurisdiction over the District Court’s final order pursuant to 28 U.S.C. § 1291. In
determining whether an applicant is disabled within the meaning of the Act, and therefore
eligible for benefits, the Commissioner applies the familiar five-step sequential evaluation
process. The Commissioner inquires, in turn, whether an applicant: (1) is engaged in
substantial gainful activity; (2) suffers from an impairment or combination of
impairments that is “severe”; (3) suffers from an impairment or combination of
impairments that meets or equals a listed impairment; (4) is able to perform his or her past
relevant work; and (5) is able to perform work existing in significant numbers in the
national economy. See 20 C.F.R. §§ 404.1520(a)-(f), 416.920(a)-(f).
The Commissioner may deny an applicant’s claim for failure to establish the
existence of a “severe impairment” at step two of the sequential framework. But step two
should rarely be the stage at which an applicant’s claim is rejected. “The step-two inquiry
is a de minimis screening device to dispose of groundless claims[,]” Newell v.
Commissioner of Social Security, 347 F.3d 541, 546 (3d Cir. 2003) (citations omitted),
and “because step two is to be rarely utilized as basis for the denial of benefits, its
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invocation is certain to raise a judicial eyebrow.” McCrea v. Commissioner of Social
Security, 370 F.3d 357, 361 (3d Cir. 2004) (citation omitted). “An impairment or
combination of impairments can be found ‘not severe’ only if the evidence establishes a
slight abnormality or a combination of slight abnormalities which have ‘no more than a
minimal effect on an individual’s ability to work.’” Newell, 347 F.3d at 546 (quoting
Social Security Ruling 85-28, 1985 SSR LEXIS 19, at *6-7). “Only those claimants with
slight abnormalities that do not significantly limit any ‘basic work activity’ can be denied
benefits at step two.” Id. (quoting Bowen v. Yuckert, 482 U.S. 137, 158 (1987)
(O’Connor, J., concurring)). “If the evidence presented by the claimant presents more
than a ‘slight abnormality,’ the step-two requirement of ‘severe’ is met, and the sequential
evaluation process should continue.” Id. (citation omitted). “Reasonable doubts on
severity are to be resolved in favor of the claimant.” Id. at 547.
Notwithstanding the de minimis burden imposed at step two, the ALJ denied
Appellant’s claim at step two in the face of evidence demonstrating that Appellant’s
seizure disorder was more than a “slight abnormality,” and had more than a “minimal
effect on [Appellant’s] ability to work.” As noted, Appellant consulted Dr. Carran in the
Spring of 2002. Dr. Carran ordered a brain MRI and electroencephalogram (“EEG”)
monitoring of Appellant, and reviewed video of Appellant suffering seizures at night.
Following her examination of Appellant, Dr. Carran issued a medical report stating that
Appellant was epileptic and suffered one to four complex partial seizures per day and
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secondary generalized seizures at night. She opined that Appellant was impaired
cognitively and mentally by frequent, daily generalized and partial seizures, and that
Appellant’s memory was poor. She concluded that Appellant was limited to
lifting/carrying 1-2 pounds, that standing/walking was uncertain, and that Appellant was
“completely disabled” and unable to work.
The ALJ found that Dr. Carran’s conclusions lacked a “medical basis.” We
disagree. Dr. Carran’s assessment was based on the MRI and EEG testing, video
evidence, and her own medical examination, all of which revealed Appellant’s ongoing
seizure disorder. Dr. Carran detailed her findings in the medical report contained in the
record before the ALJ. We find the evidence of “severe impairment” set forth in Dr.
Carran’s report sufficient to satisfy step two, and conclude that the ALJ erred in
concluding otherwise.
The Commissioner stresses on appeal that the issue here is not whether Appellant
“has a seizure disorder, but rather whether her seizure disorder could be controlled by
Dilantin or other medication... .” The Commissioner contends that Appellant’s seizures
were remediable with medication and therefore could not be step-two “severe
impairments” because impairments which are remediable cannot constitute the basis for
disability under the regulations. There is evidence in the record that in 1999-2000,
Dilantin did control Appellant’s seizures. But Dr. Carran opined in 2002 that Dilantin
was a “failed medication,” and switched Appellant to different medications. And
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Appellant testified at the 2002 hearing before the ALJ that she continued suffering
seizures despite the Dilantin. Thus, the only then-fresh evidence concerning the
effectiveness of Dilantin supports Appellant’s position that her seizures were not
remediable by Dilantin.
Based on the evidence in the record, particularly the evidence from Dr. Carran’s
2002 treatment of Appellant, we find that the District Court erred in denying Appellant’s
claim at step two of the sequential evaluation. We will therefore reverse the order of the
District Court and remand with instructions to remand the matter to the Commissioner for
further proceedings consistent with this opinion.
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